Sector portfolio · Corporate investor · United States
Eli Lilly's AI portfolio
Eli Lilly has backed 13 AI startups in rounds we track, $1.4B between them, shown by the stage each has reached. The best-funded is Alto Neuroscience.
Funding by segment
- Series A$190M4
- Series C and later$527M3
- Stage not reported$306M2
- Pre-seed and seed$4.0M2
- Series B$386M2
Where they are based
- United States13$1.4B
United StatesFounded
2 without a founding year on record.
Total raised
- Under $1M1
- $1M to $10M1
- $10M to $50M3
- $50M to $250M6
- $250M to $1B2
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
10 of 13 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States13
Startups by country, 1 country in all.
Segment by segment
Series A
4 startups · $190M raised
Rezo TherapeuticsRezo Therapeutics is a biopharmaceutical company based in San Francisco, founded in 2021.United States$78M
Excelsior SciencesExcelsior Sciences is a biotechnology company based in New York City, founded in 2024.United States$70M
Iterative ScopesIterative Scopes delivers tools for physicians and life sciences in colorectal cancer and inflammatory bowel disease space.United States$30M
Persist AIPersist AI is a biotechnology company that builds long-acting microsphere formulations.United States$12M
Series C and later
3 startups · $527M raised
Iterative HealthIterative Health is a healthcare technology and services company based in Cambridge, Massachusetts, with an additional office in NUnited States$227M
BigHat BiosciencesBigHat Biosciences is a biotechnology company founded in 2019 and based in San Mateo, California.United States$150M
AbsciAbsci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential oUnited States$150M
Stage not reported
2 startups · $306M raised
Alto NeuroscienceAlto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.United States$270M
Verge GenomicsVerge Genomics uses machine learning and human genomics to accelerate drug discovery.United States$36M
Pre-seed and seed
2 startups · $4.0M raised
RevistoWe're enabling the next generation of data-driven, personalized, and engaging life sciences marketing through streamlined, AI-poweUnited States$4.0M
basys.aibasys.ai is a healthcare technology startup based in Cambridge, Massachusetts, founded in early 2022 by Amber Nigam and Jie Sun.United States$25K
Series B
2 startups · $386M raised
DELFI DiagnosticsDELFI Diagnostics is a biotechnology company founded in 2019 that focuses on early cancer detection through a blood-based liquid bUnited States$259M
Moonwalk BiosciencesMoonwalk Biosciences is an early-stage, pre-clinical therapeutics company based in South San Francisco, California, with an additiUnited States$127M
How this map is made. Every startup here works in AI and has raised money in a round we track that names Eli Lilly as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Eli Lilly?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.